This comprehensive pharmacogenomics eBook was curated for you to gain valuable knowledge and insights into the rapidly advancing field of precision medicine. This eBook focuses on three key areas: ...

Pharmacogenomics has the potential to revolutionize the prevention, diagnosis, and treatment of infectious diseases. The application of pharmacogenomics to infectious diseases is in its infancy.

"Pharmacogenomics embodies a new frontier in precision medicine, enabling us to fine-tune treatments to the genetic profiles of individual patients," says Dr. Catherine Oliver, PharmD, BCPS, DPLA ...

Pharmacogenomics looks at how a person’s body metabolizes a particular medication, if the medication will work for that patient, and the potential side effects the patient could face.

Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and non-responders to medications. New and ...

The pharmacogenomics sector is constantly changing. For example, in March 2024, the FDA 2 made labelling changes to injectable 5-fluorouracil (5-FU, capecitabine (Xeloda)) ...

Pharmacogenomics studies how the genetics of an individual impacts their response to drugs. It aims at better human health by personalizing treatment according to genetic composition. Also, it ...

Pharmacogenomics (PGx) is a subset of precision medicine that focuses on the genetics behind different pharmaceutical interactions, toxicities, and efficacies. PGx improves drug discovery and ...

Furthermore, pharmacogenomics can lead to better-informed decisions on medication pricing, focusing on the value of effective treatments, which can ultimately influence healthcare costs in a ...

Our Pharmacogenomics and Transport micro-credential is a three-course series encompassing several aspects of pharmacogenomics from transport to current events incorporating cancer and nutrition. Each ...

US-based genomics company Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio to offer personalised patient care in neurology and oncology. The suite includes a ...